Detalhe da pesquisa
1.
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-up From a Phase 3 Trial.
J Urol
; : 101097JU0000000000004020, 2024 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704840
2.
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Lancet Oncol
; 22(1): 107-117, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33253641
3.
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
N Engl J Med
; 376(20): 1921-1932, 2017 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28514601
4.
Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial.
Eur Urol
; 81(3): 223-228, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34933753
5.
A randomized, double-blind, placebo-controlled trial of a selective COX-2 inhibitor, GW406381, in patients with postherpetic neuralgia.
J Pain
; 10(6): 654-60, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19409858
6.
Evaluation of GW406381 for treatment of osteoarthritis of the knee: two randomized, controlled studies.
Medscape J Med
; 10(11): 259, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19099009
7.
The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects.
Br J Clin Pharmacol
; 61(2): 191-9, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16433873